Page last updated: 2024-11-07

idoxuridine and Glioblastoma with Sarcomatous Component

idoxuridine has been researched along with Glioblastoma with Sarcomatous Component in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kassis, AI4
Adelstein, SJ4
Sahu, SK2
Wen, PY3
Foulon, CF1
Nagel, JS1
Black, PM2
Van den Abbeele, AD1
Baranowska-Kortylewicz, J1
Makrigiorgos, GM1
Metz, KR1
Matalka, KZ1
Cook, CU1
Manome, Y1
Kunieda, T1
Koga, T1
Kufe, DW1
Ohno, T1

Reviews

1 review available for idoxuridine and Glioblastoma with Sarcomatous Component

ArticleYear
Preclinical animal studies with radioiododeoxyuridine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4 Suppl

    Topics: Animals; Brain Neoplasms; Female; Gliosarcoma; Idoxuridine; Iodine Radioisotopes; Mice; Neoplasms, E

1996

Other Studies

4 other studies available for idoxuridine and Glioblastoma with Sarcomatous Component

ArticleYear
5-[125]iodo-2'-deoxyuridine in the radiotherapy of solid CNS tumors in rats.
    Acta oncologica (Stockholm, Sweden), 1996, Volume: 35, Issue:7

    Topics: Animals; Brain Neoplasms; Gliosarcoma; Idoxuridine; Iodine Radioisotopes; Male; Neoplasm Transplanta

1996
Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:3

    Topics: Animals; Area Under Curve; Autoradiography; Gliosarcoma; Idoxuridine; Injections, Spinal; Iodine Rad

1997
5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998, Volume: 39, Issue:7

    Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; DNA; Gliosarcoma; Idoxuridine; Injections, I

1998
Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: activation by ionizing radiation or uptake of radioactive iododeoxyuridine.
    Human gene therapy, 1998, Jul-01, Volume: 9, Issue:10

    Topics: Animals; beta-Galactosidase; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression

1998